Diamyd Medical AB (OSTO:DMYD B) Change In Payables And Accrued Expense : kr0.00 Mil (TTM As of May. 2025)

View and export this data going back to 2013. Start your Free Trial

What is Diamyd Medical AB Change In Payables And Accrued Expense?

Diamyd Medical AB's Change In Payables And Accrued Expense for the quarter that ended in May. 2025 was kr0.00 Mil. It means Diamyd Medical AB's Accounts Payable & Accrued Expense stayed the same from Feb. 2025 to May. 2025 .

Diamyd Medical AB's Change In Payables And Accrued Expense for the fiscal year that ended in Aug. 2024 was kr0.00 Mil. It means Diamyd Medical AB's Accounts Payable & Accrued Expense stayed the same from Aug. 2023 to Aug. 2024 .

Diamyd Medical AB Change In Payables And Accrued Expense Historical Data

The historical data trend for Diamyd Medical AB's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diamyd Medical AB Change In Payables And Accrued Expense Chart

Diamyd Medical AB Annual Data

Trend

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Aug24

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

Diamyd Medical AB Quarterly Data
	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25	May25
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

Diamyd Medical AB Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in May. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

Diamyd Medical AB Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Diamyd Medical AB's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Diamyd Medical AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Diamyd Medical AB (OSTO:DMYD B) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

DYMDF:USA

Address

Kungsgatan 29, Stockholm, SWE, SE-111 56

Website

https://www.diamyd.com

Diamyd Medical AB is a Sweden-based company engaged in the field of pharmaceutical development. It develops therapies using in-licensed substances glutamic acid decarboxylase (GAD) and GABA for the prevention or treatment of diabetes and other inflammatory diseases. The firm is focused on finding the cure for diabetes and other serious inflammatory diseases through pharmaceutical development and investments in stem cells and medical technology. Its product portfolio consists of Diamyd, for the treatment of autoimmune diabetes; Remygen, a regenerative and immunomodulatory therapy for the treatment of autoimmune diabetes and type 2 and type 1 diabetes.

Diamyd Medical AB Headlines

No Headlines